alexa Abstract | 2-Substituted-5-(5-nitro-furan-2-yl)-1,3,4-thiadiazoles: Anti-Helicobacter pylori activity evaluation and docking study

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access

Abstract

Helicobacter pylori causes gastric and gastroduodenal ulcer disease and chronic infection of H. pylori is attributed to adenocarcinoma. 2-Substituted-5-(nitro-aryl)-1,3,4-thiadiazoles are being extensive evaluated against H. pylori isolates. In this study, a series of 2-Substituted-5-(5-nitro-furan-2-yl)-1,3,4-thiadiazoles selected and evaluated for anti-Helicobacter pylori activity. Molecular docking simulation on H. pylori urease active site improves showed potential interaction between selected ligands and H. pylori urease. In this study in vitro anti-Helicobacter pylori assay was evaluated for some selected 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazole containing compounds. Docking simulation for designed compound was performed to explain mechanism of interactions. It was found that most compounds exhibited significant anti-Helicobacter pylori activity more potent than the standard drug metronidazole. In vitro anti-Helicobacter pylori activity was performed that 2-(5-(5-nitrofuran-2-yl)-1,3,4- thiadiazol-2-ylthio)-N-propylacetamide was the most potent compound among all tested compounds against clinical isolates of H. pylori. Development of new 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol derivatives containing thio-linker (N-(alkyl) acetamides) as potentially potent anti-Helicobacter pylori agents is greatly suggested.

To read the full article Peer-reviewed Article PDF image

Author(s): Farhad Alvandifar Azar Tahghighi Reyhaneh Sabourian Loghman FiroozpourMohammad Mahdavi Parastoo Saniee Najme Edraki Mohammad Hassan MoshafiAbbas Shafiee and Alireza Foroumadi

Keywords

Helicobacter pylori, 1,3,4-thiadiazole, gastric ulcer

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords